Last reviewed · How we verify
NCT06819124
Examining Interactions Between PALS and Caregivers
NA trial testing Structured Communicative Interaction in Amyotrophic Lateral Sclerosis (ALS) in 152 participants. Currently enrolling.
28 February 2029
Quick facts
| Lead sponsor | Penn State University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 152 |
| Start date | 22 January 2025 |
| Primary completion | 28 February 2029 |
| Estimated completion | 28 February 2029 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Structured Communicative Interaction
- Unstructured communicative interaction
Conditions studied
- Amyotrophic Lateral Sclerosis (ALS) — all drugs for Amyotrophic Lateral Sclerosis (ALS) →
Sponsor
Penn State University
Who can join
Adults 18 to 90, any sex, with Amyotrophic Lateral Sclerosis (ALS). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to learn about the effect of communicative interaction on verbal communication in people with amyotrophic lateral sclerosis (ALS) and their caregivers. The question is, What are the effects of communicative interaction on verbal communication in people with ALS when they interact with their caregivers and does this change over time? Participants will read words and sentences while they are interacting with their caregivers.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06819124
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Structured Communicative Interaction
Trials testing the same drug.
- NCT06266403 — Evaluating Verbal Communication in Structured Interactions: Theoretical and Clinical Implications · NA · recruiting
Other recruiting trials for Amyotrophic Lateral Sclerosis (ALS)
Currently open trials in the same condition.
- NCT06608004 — Influence of Olfacto-gustatory Sensoriality on the Nutritional Status of Patients With Amyotrophic Lateral Sclerosis · recruiting
- NCT07187388 — Investigating the Impact of Electrical Stimulation on Facial Pain, Jaw Movement and Oral Health in People With Motor Neu · NA · recruiting
- NCT07233148 — Healing ALS Registry Observational Study (HAROS) · recruiting
- NCT07257302 — Lung Insufflation Capacity Training and Respiratory Function in Amyotrophic Lateral Sclerosis · NA · recruiting
- NCT07118319 — The Safety, Tolerability and Preliminary Efficacy of Derived Motor Neuron Progenitor Cells (XS228CN) in Subjects With Am · Phase 1 · recruiting
Other Penn State University trials
Trials by the same sponsor.
- NCT07147387 — Lions Hearts: A Community Approach to Multigenerational Cardiovascular Disease Risk · NA · not yet recruiting
- NCT07266506 — Development of an Eating Behavior Risk Score · NA · not yet recruiting
- NCT07229781 — Mediterranean Diet and Blood Sugar Study · NA · not yet recruiting
- NCT07235358 — Cardiometabolic Effects of Pecan Snacking in Prediabetes · NA · not yet recruiting
- NCT06823518 — Thrive Initiative Parent-Education Programming Study · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06819124 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Penn State University
- Last refreshed: 6 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06819124.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing